Cargando…
Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)
SIMPLE SUMMARY: Immune checkpoint inhibitor (ICPi)-induced thyroid dysfunction is a frequent immune-related adverse event (irAE). ICPi-induced thyrotoxicosis is usually the first stage of a biphasic thyroiditis with secondary hypothyroidism, whereas ICPi-induced Graves’ disease (GD), due to the stim...
Autores principales: | Peiffert, Mathilde, Cugnet-Anceau, Christine, Dalle, Stephane, Chikh, Karim, Assaad, Souad, Disse, Emmanuel, Raverot, Gérald, Borson-Chazot, Françoise, Abeillon-du Payrat, Juliette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073133/ https://www.ncbi.nlm.nih.gov/pubmed/33920721 http://dx.doi.org/10.3390/cancers13081944 |
Ejemplares similares
-
Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up
por: Levy, Manon, et al.
Publicado: (2020) -
Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices
por: Raverot, Véronique, et al.
Publicado: (2020) -
Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report
por: Lemelin, Annie, et al.
Publicado: (2019) -
Graves’ orbitopathy post-SARS-CoV-2 vaccines: report on six patients
por: Abeillon-du Payrat, J., et al.
Publicado: (2022) -
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
por: Castellnou, Solène, et al.
Publicado: (2020)